Unit 3 - Narcotic Analgesics Flashcards Preview

MSII Pharmacology > Unit 3 - Narcotic Analgesics > Flashcards

Flashcards in Unit 3 - Narcotic Analgesics Deck (43):
1

what is the general structure of opioids?

5 ring structure with substitutions at 3, 6, and 17 that create the profile

2

what are endogenous opioid peptides? their function?

endorphins
-share protein sequences "Opioid motif"
-precursor has commonality with ACTH, MSH, b-LPH
--ACTH may account for stress analgesia
-inhibit responses to painful stimuli
-modulate GI, endocrine, autonomic function
-rewarding (addicting) properties

3

where are opioid receptors found?

in the brain, spinal cord, and peripheral receptors

4

what do agonists to opioid receptors do?

-inhibit release of substance P and inhibit ascending transmission from dorsal horn
-activates pain control circuits descending from midbrain

5

what is the structure of opioid receptors and how they're activated?

GPCR
-ligand recognition on extracellular domain
-transmembrane and intracellular domains
-G proteins bind to cytoplasmic aspect of receptor
-activates/binds GTP to G-protein
-activates effector protein, inhibits AC, activates receptor-operated K currents, and suppresses voltage-gated Ca currents (inhibits substance P)

6

what are the opioid receptor subtypes? most important?

1. Mu opioid receptor (MOR) - most important for analgesia, most prescribed opioids
2. Delta opioid receptor (DOR) - analgesia but not across BBB
3. Kappa opioid peptide receptor (KOR)
4. Nociceptin opioid receptor (N/OFQ or NOR) - orphanin FQ

7

what do opioid side effects depend on?

receptor subtypes

8

explain the mechanism of tolerance for opioids?

modification of opioid receptors
-decreased effectiveness with repeated administration
-short term desensitization: phosphorylation or receptor internalization
-long term tolerance: additional mechanisms

can also get tolerant of side effects EXCEPT constipation

9

what are side effects of opioids?

-analgesia
-mood alteration/reward
-neuroendocrine
-miosis
-convulsions (lowers seizure threshold)
-depressed respiration (most fatal)
-antitussive
-nausea/emesis
-GIT issues
-GU issues
-skin (vasodilation, urticaria)

10

what is the max serum concentration reached for the different methods of administration? the half life?

oral: 1 hour
sub-cutaneous or intra-muscular: 30 minutes
IV: 6 minutes

half life at steady state is the same for all methods = 3-4 hours

11

what is the duration of effect of "immediate-release" formulations (except methadone)?

3-5 hours (shorter with parenteral bolus)

12

what is the bolus effect?

swings in plasma concentration
-drowsiness 1/2 to 1 hour after ingestion
-pain before next dose due
-must move to ER preparation, continuous SC, or IV infusion

13

morphine

2 major metabolites: morphine-6-glucuronide and morphine-3-glucuronide
-M6G: active metabolite and higher potency
-M3G: little receptor affinity
-for severe pain

14

codeine

low recceptor affinity, but analgesia is due to conversion to morphine
-only 10% is demethylated to morphine, and for mild-moderate pain
-conversion is effected by CYP2D6
--10% of Caucasians cannot convert, and experience side effects without analgesia
-antitussive action may involve other receptors that bind codeine itself

15

tramadol

synthetic codeine analog, but weak Mu agonist
-demethylated metabolite is more potent analgesic
-part of analgesia from inhibition of NE and serotonin uptake
-for mild to moderate pain, and as effective as morphine or meperidine
-less effective for severe pain
-less constipating

16

fentanyl

very potent, very long half life, and many forms
-much more lipid soluble than morphine
-delayed effect and toxicity are common
-transdermal patch useful for long term Rx
--ensure adherence to skin (must shave hair)
--may not be as effective if patient is very thin, as there is no adipose tissue
-wait a week between dose changes, or else trouble with iatrogenic overdose
-for severe pain

17

methadone

extended duration of action
-90% bound to plasma proteins and gradual accumulation in tissues
-used in treatment of chronic pain, and treatment of heroin users
-affordable, but must be careful with dosage
-for severe pain

18

oxycodone

very effective, potent oral analgesic for severe pain
-short and long-acting
-long acting form oxycontin has seen widespread abuse and overdoses

19

what is Percocet?

oxycodone + acetaminophen

20

meperidine

no longer recommended b/c of metabolite toxicity (normeperidine)
-congeners for treatment of diarrhea:
--diphenoxylate (Lomotil)
--loperamide (Immodium)
--mech: slow peristalsis via opioid receptors in intestine, and possibly decreased GI secretion

21

naloxone

opioid antagonist used in treatment of opioid toxicity (IV bolus and continuous infusion)
-administered parenterally (oral almost completely metabolized by liver)
--effective immediately, but only lasts 15 minutes so require IV drip

22

naltrexone

opioid antagonist used in treatment of alcoholism

23

what is the caution of using opioids and acetaminophen?

many commonly prescribed opioids come in this combo form, which can be other the counter
-easy to inadvertantly take too much acetaminophen (max dose is 3000 mg/24 hours)

24

what is routine oral dosing for immediate-release preparations?

codeine, hydrocodone, morphine, hydromorphone, oxycodone
-dose q 4 h, and adjust daily
--mild/moderate pain increase by 25-50%
--severe/uncontrolled pain by 50-100%

25

what is routine oral dosing for extended-release preparations?

improve compliance, adherence
-dose q 8, 12, or 24 h (product specific)
-don't crush or chew tablets
-may flush time-release granules via feeding tube
-adjust dose q 2-4 days (steady state reached)
--adjust methadone dose q 4-7 days (longer half-life and risk of overdose)

26

what is breakthrough dosing?

if currently on opioids, but then PT makes the pain worse
-use immediate-release opioids, NOT ER release
--5-15% of a 24-hour dose
--offer after Cmax reached
---po/pr: q 1 hr
---SC, IM: q 30 min
---IV: q 10-15 min

27

what are clearance concerns with opioids?

conjugated by liver
-90-95% excreted in urine
-dehydration, renal failure, severe hepatic failure
--decreased dosing interval and size if oliguria or anuria
---STOP routine dosing of morphine, and use ONLY as needed

28

what are mixed agonist-antagonist opioids?

not recommended
-pentazocine, butorphanol, nalbuphine, dezocine
--compete with agonists --> withdrawal
--analgesic ceiling effect
--high risk of psychotomimetic adverse effects with pentazocine, butorphanol

29

what must be considered before labeling patient as "opioid addict"?

1. substance use = true addiction
2. pseudoaddiction = undertreatment of pain
3. behavioral/family/psychological disorder
4. drug diversion

30

what is physical dependence?

not tolerance, but a process of neuroadaptation
-abrupt withdrawal may cause abstinence syndrome
--agitation, abdominal pain, N/V, diarrhea, yawning, piloerection
-to avoid, reduce dose by 50% every 2-3 days (taper dose out)
-antagonists will cause abrupt withdrawal symptoms

31

how do you manage pain in substance abusers?

management is more complex, with protocols and contracting
-consultation with pain or addiction specialists is important

32

what happens if pain is poorly responsive to opioids?

dose escalation may cause adverse effects
-try alternate route or rotate opioid
-try coanalgesic
-use nonpharmacologic approach

33

what is equianalgesic dosing?

necessary to convert to alternative routes of delivery (transitions in/out of hospital, severeity of pain)
-must convert between opioids while maintaining analgesia (insurance change, intolerable ASE, etc.)
-use a table to find initial dose selection
-significant first pass metabolism

34

what are common and uncommon ASE of opioids?

common: constipation, dry mouth, N/V, sedation, sweats
uncommon: bad dreams/hallucinations, dysphoria/delirium, myoclonus/seizures, puriritus/urticaria, respiratory depression, urinary retention

35

when does sedation from opioids start and what do you do?

onset with start of opioids
-must distinguish from exhaustion due to pain
-tolerance develops within days
-if persistent, change opioid or route
-psychostimulants may be useful (methylphenidate)

36

what is the presentation of opioid delirium? how to minimize risk?

presentation:
-confusion, ad dreams, hallucinations
-restlessness, agitation
-myoclonic jerks, seizures
-depressed level of consciousness
-respiratory depression

minimize risk by following dosing guidelines
-check liver/kidney function and ensure well hydrated

37

explain respiratory depression with opioids?

loss of consciousness precedes respiratory depression (major cause of death0
-tolerance is rapid
-manage by identifying and treating contributing causes
--reduce opioid dose and observe
-if unstable vital signs, O2 sat, or CO2 retention, use naloxone

38

what is opioid allergy?

rare, but be sure to separate from ASE
-urticaria and bronchospasm can be allergies, and need careful assessment

39

what is urticaria from opioids?

much more common than allergy
-mast cell destabilization by morphine, hydromorphone
-treat with routine, long-acting, nonsedating antihistamines such as fexofenadine and loratadine

40

explain constipation with opioids?

common to all opioids
-effects on CNS, spinal cord, myenteric plexus of gut
-easier to prevent than to treat, but dietary approach is ineffective
-bulk forming agents contraindicated, so use stimulant laxative + stool softener (senna + docusate Na)
--prokinetic agents are expensive but work, as do osmotic laxatives

41

explain N/V with opioids

onset with start of opioids
-tolerance develops within days
-prevent or treat with DA-blocking antiemetics (prochlorperazine or metoclopramide)
-may need alternative opioid

42

what is opioid-induced hyperalgesia?

mechanism unclear, but possibly nociceptive sensitization caused by exposure to opioids

43

what is the role of opioids and chronic non-cancer pain?

benefits and risks
-multiple guidelines available based on safety and efficacy
-widespread prescriptions have resulted in increasing substance abuse
-use of opiates in CNCP requires caution before starting, contracts and urine testing